Mirae Asset Healthcare Fund

Mirae Asset Mutual FundThematicPortfolio as of 31 July 2026

Mirae Asset Healthcare Fund holds 30 instruments (98.74% equity), led by Sun Pharmaceutical Industries Limited (11.06%), Divi's Laboratories Limited (8.71%) and Torrent Pharmaceuticals Limited (7.47%), as of its 31 July 2026 SEBI-mandated monthly disclosure.

Holdings
30
Equity Allocation
98.74%
AMC
Mirae Asset Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of Mirae Asset Healthcare Fund, managed by Mirae Asset Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 30 instruments with an equity allocation of 98.74%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

Mirae Asset Healthcare Fund's top 10 holdings account for 58.25% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 97.69% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 0 new positions and exited 1 position, with Torrent Pharmaceuticals Limited seeing the largest move (+7.01pp to 7.47%).

Top 10 Equity Holdings

What Changed: June 2026 → July 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

1 exit6 increased10 reduced

Biggest Weight Increases

StockWeightChange
Torrent Pharmaceuticals Limited0.46% → 7.47%▲ +7.01
Biocon Limited0.52% → 2.08%▲ +1.56
Divi's Laboratories Limited7.53% → 8.71%▲ +1.18
Laurus Labs Limited4.61% → 5.13%▲ +0.52
Dr. Lal Path Labs Ltd.2.57% → 2.81%▲ +0.24
Sun Pharmaceutical Industries Limited10.95% → 11.06%▲ +0.11

Biggest Weight Reductions

StockWeightChange
Dr. Reddy's Laboratories Limited4.33% → 3.46%▼ -0.87
Lupin Limited4.13% → 3.27%▼ -0.86
Glenmark Pharmaceuticals Limited6.09% → 5.53%▼ -0.56
Aurobindo Pharma Limited4.33% → 3.82%▼ -0.51
Gland Pharma Limited2.49% → 2.11%▼ -0.38
Krishna Institute of Medical Sciences Limited3.85% → 3.48%▼ -0.37
Eris Lifesciences Limited3.16% → 2.82%▼ -0.34
Fortis Healthcare Limited3.8% → 3.55%▼ -0.25
Max Healthcare Institute Limited3.06% → 2.81%▼ -0.25
Cipla Limited3.19% → 3.03%▼ -0.16

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).

Feb: 11.77%, Mar: 12.2%, Apr: 11.76%, May: 11.13%, Jun: 10.95%, Jul: 11.06%
11.06%
Feb: 8.16%, Mar: 7.93%, Apr: 8.23%, May: 8.03%, Jun: 7.53%, Jul: 8.71%
8.71%
Feb: 0.49%, Mar: 0.49%, Apr: 0.46%, May: 0.46%, Jun: 0.46%, Jul: 7.47%
7.47%
Feb: 6.38%, Mar: 6.15%, Apr: 5.93%, May: 6.04%, Jun: 6.09%, Jul: 5.94%
5.94%
Feb: 6.93%, Mar: 6.94%, Apr: 7.12%, May: 6.4%, Jun: 6.09%, Jul: 5.53%
5.53%

Full Portfolio (30 holdings)

#HoldingSector% to NAV
1Sun Pharmaceutical Industries LimitedHealthcare11.06%
2Divi's Laboratories LimitedHealthcare8.71%
3Torrent Pharmaceuticals LimitedHealthcare7.47%
4Apollo Hospitals Enterprise LimitedHealthcare5.94%
5Glenmark Pharmaceuticals LimitedHealthcare5.53%
6Laurus Labs LimitedHealthcare5.13%
7Aurobindo Pharma LimitedHealthcare3.82%
8Alkem Laboratories LimitedHealthcare3.56%
9Fortis Healthcare LimitedHealthcare3.55%
10Krishna Institute of Medical Sciences LimitedHealthcare3.48%
11Dr. Reddy's Laboratories LimitedHealthcare3.46%
12Lupin LimitedHealthcare3.27%
13Onesource Specialty Pharma LimitedHealthcare3.23%
14Sai Life Sciences LimitedHealthcare3.17%
15Aster DM Healthcare LimitedHealthcare3.14%
16IPCA Laboratories LimitedHealthcare3.13%
17Cipla LimitedHealthcare3.03%
18Eris Lifesciences LimitedHealthcare2.82%
19Dr. Lal Path Labs Ltd.Healthcare2.81%
20Max Healthcare Institute LimitedHealthcare2.81%
21Gland Pharma LimitedHealthcare2.11%
22Biocon LimitedHealthcare2.08%
23Mankind Pharma LimitedHealthcare2.04%
24TREPStreps1.38%
25Narayana Hrudayalaya Ltd.Healthcare1.19%
26Anthem Biosciences LimitedHealthcare1.15%
27Neogen Chemicals LimitedMaterials0.61%
28Deepak Nitrite LimitedMaterials0.44%
29Mirae Asset Liquid Fund - Direct Plan - Growthmf0.01%
30Net Receivables / (Payables)other-0.13%

Frequently Asked Questions

Yes. As of its 31 July 2026 disclosure, Sun Pharmaceutical Industries Limited is 11.06% of Mirae Asset Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 31 July 2026 disclosure, Divi's Laboratories Limited is 8.71% of Mirae Asset Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 31 July 2026 disclosure, Torrent Pharmaceuticals Limited is 7.47% of Mirae Asset Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 31 July 2026 disclosure, Apollo Hospitals Enterprise Limited is 5.94% of Mirae Asset Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 31 July 2026 disclosure, Glenmark Pharmaceuticals Limited is 5.53% of Mirae Asset Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: Mirae Asset Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.